The global demand for Strand Displacement Amplification (SDA) Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Strand Displacement Amplification (SDA) allows in-vitro nucleic acid amplification method for DNA amplification using isothermal technique. Over the years, SDA has emerged as the well-developed technique of nucleic acid amplification through co-ordinated activity of restriction enzyme and DNA polymerase. This technique was first developed in the year 1992 by Walker. Nucleic acid plays crucial role in accurate diagnosis of various inherited medical conditions. Strand displacement amplification technology is the first ever technique for detection of hereditary diseases with the real-time homogeneous fluorescence-based detection method.
The market growth is mainly driven by increasing rate of hereditary diseases is driving the demand for SDA market. Rise in count of infectious as well as chronic diseases is fuelling the demand for SDA market. World Health Organization states that 1 in 3 people in the world have been infected by either HBV or HCV. Inadequate skilled medical professionals is impacting the market growth negatively.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of strand displacement amplification (SDA).
The entire strand displacement amplification (SDA) market has been sub-categorized into application and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By End User
- Research Institutes
- Diagnostic Laboratories
This section covers regional segmentation which accentuates on current and future demand for strand displacement amplification (SDA) market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Strand Displacement Amplification (SDA) Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the strand displacement amplification (SDA) market include New England Biolabs, Hopax Fine Chemicals, Nippon Genetics .Co .Ltd., G Biosciences, BioRad, Proteon Pharmaceutical. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.